drugset / Trial / NCT00443040

Asimadoline for the Treatment of Post-Operative Ileus

NCT00443040 ↗

Phase 2 Terminated 35 enrolled Tioga Pharmaceuticals RTI Health Solutions · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.

Timeline

Start
2007-01
Primary completion
2008-02
Completion
2008-02

Outcome

Outcome not reported

Stopped (Enrollment): “poor enrollment (31 of a planned 114 subjects were randomized and evaluable)”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Asimadoline Small molecule 1 mg —
Comparator Asimadoline Small molecule 3 mg —

Indications